Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Public Encouraged to Vote for 2 Students with CF to Receive $22K AbbVie Scholarships AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC FAQs About Cystic Fibrosis Professor Launches Research Initiative to Encourage Students to Develop and Test Antibiotics for CF Infections Public Encouraged to Vote for 2 Students with CF to Receive $22K AbbVie Scholarships Sep 30, 2019 07:00 am | Marisa Wexler MS Voting for two students to receive two scholarships — valued at $22,000 each — is now open to the public until Oct. 9, pharmaceutical company AbbVie has announced. After the voting period, AbbVie’s 2019 Thriving Undergraduate Scholarship will be awarded to an undergraduate student with CF, and its Thriving Graduate Scholarship to a graduate CF […] The post Public Encouraged to Vote for 2 Students with CF to Receive $22K AbbVie Scholarships appeared first on Cystic Fibrosis News Today. Read More AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients Sep 27, 2019 07:00 am | Marisa Wexler MS The investigational therapy MS1819 showed positive safety results in a Phase 2 clinical trial for the treatment of exocrine pancreatic insufficiency (EPI) in people with cystic fibrosis (CF), AzurRx BioPharma announced. In people with CF, EPI can occur when mucus builds up and blocks the ducts of the pancreas. This can prevent important enzymes from getting […] The post AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients appeared first on Cystic Fibrosis News Today. Read More NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC Sep 26, 2019 09:30 am | Larry Luxner Next month’s annual conference of the National Organization for Rare Disorders (NORD) in Washington, D.C., couldn’t come at a better time, says Marshall Summar, MD, chairman of NORD’s board of directors. “The pace of discovery in rare diseases has gone from brisk to hypersonic,” Summar told BioNews Services, publisher of this website, by phone from […] The post NORD 2019 Rare Disease Summit Set for Oct. 21-22 in Washington, DC appeared first on Cystic Fibrosis News Today. Read More FAQs About Cystic Fibrosis Sep 26, 2019 08:23 am | Emily Malcolm Cystic fibrosis (CF) is a progressive, inherited disease characterized by the buildup of thick, sticky mucus that can damage many of the body’s organs. It causes persistent lung infections and limits the ability to breathe over time. Patients are usually diagnosed by the age of 1, often leaving their families with many unanswered questions about […] The post FAQs About Cystic Fibrosis appeared first on Cystic Fibrosis News Today. Read More Professor Launches Research Initiative to Encourage Students to Develop and Test Antibiotics for CF Infections Sep 26, 2019 07:00 am | Joana Carvalho, MSc Kristen Mudrack, PhD, a chemistry professor at Milligan College in Tennessee, has launched a research initiative to encourage college students to produce and test antibiotics that target and destroy Pseudomonas aeruginosa, a bacteria highly resistant to antibiotics that often causes lung infections in patients with cystic fibrosis (CF). She will discuss the project and her […] The post Professor Launches Research Initiative to Encourage Students to Develop and Test Antibiotics for CF Infections appeared first on Cystic Fibrosis News Today. Read More Recent News CF Foundation Awards Eloxx $1.61M for Phase 2 Trials in People with Nonsense Mutations I Want to Break Up with My CF Clinic Kalydeco’s Efficacy Tied to Phosphorylation Levels of CFTR Protein, Study Suggests The Benefits and Perils of Social Media Physical Activity Levels in CF Should Be Objectively Researched, Review Says